Cisplatin-triggered sensory dysfunction in NER-defective C. elegans involves GABAergic and cholinergic signaling
Johannes Krautstrunk, Emre Inan, Andre Potthoff, Ann-Kathrin Weishaupt, Thorsten Wachtmeister, Julia Bornhorst, Simone Proemel, Gerhard Fritz
Abstract
Cisplatin (CisPt) is a widely used anticancer drug that causes neurotoxicity as a dose-limiting adverse effect. DNA damage contributes to CisPt-induced neurotoxicity, yet the molecular mechanisms involved remain unclear. Here, we aim to identify pathophysiological mechanisms contributing to DNA damage-driven development of sensory neuronal dysfunction using the 3R-compliant model organism Caenorhabditis elegans. To this end, we employed the nucleotide excision repair (NER)-deficient ercc-1 mutant, which shows enhanced CisPt-induced sensory dysfunction as monitored by the chemotaxis assay, to elucidate drug-induced alterations in neurotransmission and transcriptome. We found that CisPt reduces gamma-aminobutyric acid (GABA) levels in the nematode and that GABA supplementation rescues ercc-1 mutants from CisPt-evoked sensory neurotoxicity, pointing to a neuroprotective function of GABA in the context of our study. Moreover, CisPt impairs the morphological integrity of GABAergic neurons particularly in ercc-1 mutants, which again is rescued by GABA substitution. Conversely, the cholinergic agonist carbachol impairs sensory function and exacerbates the neurotoxic effects of CisPt in ercc-1 mutants, indicating detrimental effects resulting from cholinergic excitation. Transcriptome analysis revealed that CisPt treatment stimulates a broard transcriptional response, including pathways involved in the regulation of neuronal communication, including acetylcholine-mediated neurotransmission, with pronounced effects occurring in the absence of ERCC-1. Based on these finding we suggest impaired GABAergic signaling and the loss of neuronal integrity GABAergic neurons as well as excessive cholinergic excitation as key mechanisms linking CisPt-induced DNA damage in NER defective nematodes to sensory dysfunction. Hence, targeting the balance between GABAergic inhibition and cholinergic excitation is suggested to counteract sensory neurotoxicity triggered by CisPt.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegans
C. Martinez-Fernandez, M. Bergamino, … J. Ceron·bioRxiv·Jun 3, 2021
- Connexin 43 mediated mitochondrial transfer prevents cisplatin induced sensory neurodegeneration.
Rebecca Owen, Jack Corbett, … Richard P. Hulse·bioRxiv·Oct 24, 2024
- Cisplatin neurotoxicity targets specific subpopulations and K+ channels in tyrosine-hydroxylase positive dorsal root ganglia neurons
Carrie J. Finno, Yingying Chen, … Ebenezer N. Yamoah·Frontiers in Cellular NeurosciencePeer-reviewed·May 2, 2022
- Inhibition of muscarinic receptor signaling protects human enteric inhibitory neurons against platin chemotherapy toxicity
M. N. Richter, S. Farahvashi, … F. Fattahi·bioRxiv·Mar 8, 2023
- Neuroinflammation induces nerve growth factor dependent nociceptor sensitisation in a neonatal rodent model of platinum-based chemotherapy induced neuropathic pain
Marlene E. Da Vitoria Lobo, Lydia D. Hardowar, … Richard P. Hulse·Disease Models & MechanismsPeer-reviewed·Oct 21, 2024
- Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin
F. J. Garcia-Rodriguez, C. Martinez-Fernandez, … J. Ceron·bioRxiv·Dec 12, 2017